Chapter 4 ~ Central nervous system
|
|
|
- Philomena Webb
- 5 years ago
- Views:
Transcription
1 Chapter 4 ~ Central Nervous System: Special Section 1 of 5 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics Hypnotics LOPRAZOLAM Tablet 1mg LORMETAZEPAM Tablet 500microgram PROMETHAZINE Tablet 25mg ZOLPIDEM Tablet 5mg Use in accordance with NICE (TA77) ZALEPLON Tablet 5mg, 10mg Use in accordance with NICE (TA77) Anxiolytics ALPRAZOLAM Tablet 500microgram OXAZEPAM Tablet 10mg 4.2 Drugs used in psychoses and related disorders Antipsychotic drugs Typical antipsychotics FLUPENTIXOL Tablet 3mg DI FLUPITENAZINE Tablet 1mg LEVOMEPROMAZINE Injection 25mg in Tablet 25mg PIMOZIDE Tablet 2mg; 4mg ZUCLOPENTHIXOL Injection 50mg in ACETATE (Acuphase) ZUCLOPENTHIXOL DI Tablet 2mg; 10mg Atypical antipsychotics AMISULPRIDE Solution 100mg in ARIPIPRAZOLE Tablet 50mg; 100mg; Tablet 5mg; 10mg; 15mg Liquid 1mg/ml oral solution Orodispersible Tablet 10mg; 15mg Vials 7.5mg/ml (1.3ml) Use in accordance with NICE (TA292) CLOZAPINE Tablet 25mg; 100mg Liquid 100mg in 5ml OLANZAPINE Injection 10mg (Velotab ) 5mg; 10mg Tablet 2.5mg; 5mg; 7.5mg; 10 mg
2 Chapter 4 ~ Central Nervous System: Special Section 2 of 5 QUETIAPINE Tablet 25mg; 100mg; 150mg RISPERIDONE Liquid 1mg in For care of the elderly (Quicklet ) 500microgram; 1mg Tablet 500microgram; 1mg; 2mg; 3mg; 4mg; 6mg Antipsychotic depot injections FLUPENTIXOL FLUPHENAZINE HALOPERIDOL PIPOTIAZINE PALMITATE RISPERIDONE ZUCLOPENTHIXOL Antimanic drugs LITHIUM CARBONATE LITHIUM CITRATE SEMI SODIUM VALPROATE 4.3 Antidepressant drugs Oily injection 20mg in ; 40mg in 2ml; 100mg in ; in Oily injection 25mg in ; 100mg in Oily injection 100mg in Oily injection 50mg in Injection 25mg; 37.5mg; 50mg Injection in ; 500mg in tablet CAMCOLIT modified release tablet 400mg CAMCOLIT tablet 250mg PRIADEL modified release tablet 400mg Liquid 5.4mmol lithium in 5ml (= lithium carbonate in 5ml) Tablet 250mg For care of the elderly For care of the elderly For Mental Health C.N.W.L Tricyclic and related antidepressant drugs DOXEPIN Capsule 25mg For Anaesthetist use NORTRIPTYLINE Tablet 10mg; 25mg TRAZODONE Capsule 50mg; 100mg Liquid SF 50mg in 5ml TRIMIPRAMINE Tablet 25mg Monoamine-oxidase inhibitors MOCLOBEMIDE Tablet 150mg PHENELZINE Tablet 15mg Other antidepressants drugs
3 Chapter 4 ~ Central Nervous System: Special Section 3 of 5 FLUPENTIXOL Tablet 500microgram MIRTAZAPINE 10mg; 15mg Tablet 30mg REBOXETINE Tablet 4mg VENLAFAXINE capsule 75mg Tablet 37.5mg 4.4 CNS stimulants and other drugs used for attention deficit hyperactivity disorder ATOMOXETINE METHYLPHENIDATE DEXAMFETAMINE SULFATE Capsule 10mg; 18mg; 25mg; 40mg; 60mg tablet 18mg, 27mg, 36mg capsule 5mg, 10mg, 20mg, 30mg, 40mg Tablet 5mg 4.5 Drugs used in the treatment of obesity Anti-obesity drugs acting on the gastro-intestinal tract ORLISTAT Capsule 120mg For Endocrinology Centrally acting appetite suppressants SIBUTRAMINE Capsule 10mg; 15mg 4.6 Drugs used in nausea and vertigo GRANISETRON 4.7 Analgesics Paediatric liquid SF 1mg in 5ml Sterile solution 1mg in ; 3mg in 3ml Tablet 1mg; 2mg For Endocrinology Non-opioid analgesics PARACETAMOL Opioid analgesics DIAMORPHINE FENTANYL HYDROMORPHONE Injection 10mg/ml 100ml vial Injection 5mg; 10mg; 30mg; 100mg; 500mg Tablet 10mg Lozenge 200microgram; 400microgram Capsule 1.3mg; 2.6mg capsule 2mg; 4mg; 16mg; 24mg For Anaesthetists For Obstetrics and Gynaecology
4 Chapter 4 ~ Central Nervous System: Special Section 4 of 5 MEPTAZINOL Injection 100mg in For Obstetrics METHADONE TRAMODOL MORPHINE SULPHATE Antimigraine drugs Injection 10mg in Tablet 5mg Prophylaxis of migraine BOTULINUM TOXIN TYPE A 4.8 Antiepileptics Soluble tablet 50mg Injection (preservative free) 1mg in Injection 50units, 100units For Anaesthetist use For NNU For use in chronic migraine Use in accordance with NICE (TA260) Control of epilepsy CLOBAZAM Tablet 10mg For use in epilepsy CLONAZEPAM LEVETIRACETAM OXCARBAZEPINE Oral drops 2.5mg in Oral solution SF 100mg in Tablet 250mg; 500mg Oral suspension SF 300mg in 5ml Tablet 150mg For supply on a NAMED DOCTOR and NAMED PATIENT basis ONLY PHENOBARBITAL Injection 60mg in PREGABALIN TOPIRAMATE Injection in Capsule 25mg; 75mg; 100mg; 150mg Sprinkle capsules 15mg; 25mg Tablet 25mg; 50mg; 100mg Drugs used in status epilepticus PARALDEHYDE Rectal Solution 5ml 50% in sunflower oil 4.9 Drugs used in parkinsonism and related disorders For Anaesthetists use Unlicensed Dopaminergic drugs used in parkinsonism CABERGOLINE Tablet 1mg; 2mg; 4mg CO-CARELDOPA with entacapone STALEVO Tablet 50mg / 12.5mg / Tablet 100mg / 25mg / Tablet 150mg / 37.5mg / ENTACAPONE Tablet PERGOLIDE Tablet 50microgram; 250microgram; 1mg
5 Chapter 4 ~ Central Nervous System: Special Section 5 of 5 ROPINIROLE Tablet 250microgram; 1mg STARTER PACK: 42 x 350microgram, 42 x 500microgram, 21 x 1mg FOLLOW ON PACK: 42 x 500microgram, 42 x 1mg 63 x 2mg Drugs used in essential tremor, chorea, tics and related disorders PIRACETAM Oral solution 333.3mg in Tablet 800mg RILUZOLE Tablet 50mg Use in accordance with NICE (TA20) Drugs used in essential tremor, chorea, tics and related disorders TETRABENAZINE Tablet 25mg For Huntington's Chorea Torsion dystonias and other involuntary movements BOTULINUM A TOXIN BOTOX injection 100units DYSPORT injection 500units 4.10 Drugs used in substance dependence Specialist use. Specialist use Alcohol dependence ACAMPROSATE Enteric coated tablet CALCIUM 333mg DISULFIRAM Tablet Nicotine dependence BUPROPION Tablet 150mg NICOTINE Patch 7mg / 24 hours Patch 14mg / 24 hours Patch 21mg / 24 hours VARENICLINE Tablet 500mcg, 1mg Use in accordance with NICE (TA123) Opioid dependence LOFEXIDINE METHADONE NALTREXONE BUPRENORPHINE Tablet 200microgram Mixture 1mg in Tablet 50mg Tablet 400mcg, 2mg, 8mg Use in accordance with NICE (TA114) Use in accordance with NICE (TA115) Use in accordance with NICE (TA114)
Medicines Formulary BNF Section 4 Central Nervous System
Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam
South London and the Maudsley NHS Foundation Trust Medicines Formulary
South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1
Formulary Item Restrictions and/or Advice Site availability
Formulary Item Restrictions and/or Advice Site availability C&W CNWL Typical Antipsychotic drugs Chlorpromazine 25mg Chlorpromazine 50mg Chlorpromazine 100mg Chlorpromazine 25mg/5ml syrup Chlorpromazine
Safe transfer of prescribing guidance
Safe transfer of prescribing guidance TEWV Prescriber Summary Application required before prescribing Products requiring an application, before prescribing, using the single application form Unlicensed
Chapter 4 ~ Central nervous system
Chapter 4 ~ Central Nervous System: General Section 1 of 6 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics CHLORAL HYDRATE CLOMETHIAZOLE NITRAZEPAM TEMAZEPAM TRICLOFOS
This document has been produced in collaboration with the Lancashire Commissioning Support Unit
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Date: December 2014. Reviewed August 2016. Next review Date April 2019
Joint Formulary for Psychotropic Medication.
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Page 1 Table of Contents Section Page Number Page 2 Definition of categories
NI Formulary: Chapter 4 Central Nervous system
Hypnotics Anxiolytics Acute state Non drug treatment Temazepam tablets 10mg, 20mg; oral solution 10mg/5ml or Zolpidem tablets 5mg, 10mg or Zopiclone 3.75mg, 7.5mg Non drug treatment Diazepam tablets 2mg,
FORMULARY AND PRESCRIBING GUIDELINES 2017
FORMULARY AND PRESCRIBING GUIDELINES 2017 1 Document Control Summary Issue Date Amended Section /page Author/ Amended by 1. Sept 06 All Jane Moriba Summary of Change Removed Trust policy and guideline
ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
Chapter 4 Central Nervous System
Chapter 4 Central Nervous System 4.1 Hypnotics and anxiolytics. Insomnia Underlying causes should be identified and treated e.g. depression, anxiety, pain, pruritis, and dyspnoea. In-patients who are prescribed
NSFT Formulary. Double Red Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present.
Traffic Light Status NSFT Formulary Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present. Hospital/Specialist only Drugs for which the Trust
Derbyshire Medicines Management, Prescribing and Guidelines DERBYSHIRE PRIMARY CARE FORMULARY
Derbyshire Medicines Management, Prescribing and Guidelines DERBYSHIRE PRIMARY CARE FORMULARY Chapter 4: CENTRAL NERVOUS SYSTEM Updated: March 2017 Drugs and driving From March 2015 a new driving offence
Chapter 4 Central Nervous System Answers. 1. What advice would you provide to someone who has just been initiated on Temazepam for insomnia?
Chapter 4 Central Nervous System Answers 1. What advice would you provide to someone who has just been initiated on Temazepam for insomnia? May impair judgement and increase reaction time, and so affect
4: Central Nervous System
Original Date of issue: 26/11/2005 Last eviewed:10/10/2012 Version:4 Page 1 of 25 4: entral Nervous System 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics Temazepam SF Solution (10mg/5ml) Temazepam Tablets
Pregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
Bramley Health Formulary March 2016 Review Date March 2017
Bramley Health Formulary March 2016 Review Date March 2017 This provides a formulary for use within Bramley Health. This only relates to psychiatric indications. Some of the medicines listed are also used
Index. Index. More information
acamprosate, alcohol dependence, 223 225, 227 228, 252 acetylcholine, role in Alzheimer s disease, 263 aerobic exercise, panic disorder, 81 agitation, schizophrenia sedation strategies, 21 agomelatine,
Nervous System. Chapter 4 TABLE OF CONTENTS
Chapter 4 Nervous System 2.1 Hypnotics & anxiolytics... 7 2.1.1 Hypnotics... 7 2.1.2 Anxiolytics... 7 2.2 Dependence and Withdrawal... 7 TABLE OF CONTENTS Table of Contents... 1 1 Epilepsy and other seizure
FORMULARY AND PRESCRIBING GUIDANCE
FORMULARY AND PRESCRIBING GUIDANCE GUIDELINE VERSION 18 RATIFYING GROUP Drugs and Therapeutics Group (DTG) DATE PUBLISHED NEXT REVIEW DATE (see specific guidelines) FORMULARY SPONSOR Executive Medical
West London Mental Health NHS Trust Formulary
West London Mental Health NHS Trust Formulary VERSION 3.0 (18.02.15) The Formulary is a list of medicines used for mental health indications for patients cared for in all settings of West London Mental
West London Mental Health NHS Trust Formulary
West London Mental Health NHS Trust Formulary VERSION 7.0 (09.11.16) The Formulary is a list of medicines used for mental health indications for patients cared for in all settings of West London Mental
Guide to Psychiatric Medications for Children and Adolescents
Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists
ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR
ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if
Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015
Calgary Long Term Care Formulary Pharmacy & Therapeutics February 2015 Highlights http://www.albertahealthservices.ca/4070.aspx 1 Contents February 2016... 3 Added Product(s)... 3 Not Listed, Delisted
Therapeutic Drugs Monitoring TDM 2018 Therapeutic Drugs Monitoring Scheme Application Form
complete all sections below and return to LGC Standards Proficiency Testing by email, fax or post. Returning customer Lab ID: TM Purchase order no.: (compulsory) TDM Distribution Schedule Samples for the
Medications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
Prescriber s Guide. Stahl s Essential Psychopharmacology
Stahl s Essential Psychopharmacology Prescriber s Guide FIFTH EDITION With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present this
tablet/capsule Paracetamol 500mg
Formulary Item Restrictions and/or Advice Non-opioid analgesics + compound analgesic preparations Aspirin 75mg dispersible Aspirin 300mg dispersible Aspirin 300mg Aspirin 75mg EC Paracetamol 500mg / Paracetamol
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Neuropathic pain pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist
PSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX
A acamprosate ADHD Generic Methylphenidate Equivalence, 84 Methylphenidate in Pregnancy, 9 Stimulants in Pregnancy, 50 adverse effects Antidepressant-Induced Jitteriness, 94 Antidepressants and Sexual
IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
Introduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
Psychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
Chapter 4 Central Nervous System
Chapter 4 page number 1 Chapter 4 Central Nervous System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary
Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses
Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses HPFT Medicines Formulary lists the APDs that have been approved for use, however, it does not
Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)
Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5
Use of Psychotropic Medications in Older Adults with Dementia!
Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with
FORMULARY AND PRESCRIBING GUIDANCE
FORMULARY AND PRESCRIBING GUIDANCE GUIDELINE VERSION 13 RATIFYING GROUP Drugs and Therapeutics Group (DTG) DATE PUBLISHED August 2014 NEXT REVIEW DATE (see specific guidelines) FORMULARY SPONSOR Executive
Chapter 4 Central Nervous System
Chapter 4 page number 1 Chapter 4 Central Nervous System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary
Antipsychotics. BMF 84 - Antipsychotics
Antipsychotics BMF 84 - Antipsychotics Antipsychotic medications (neuroleptics) are used for the treatment of psychosis, mainly schizophrenia and manic depression (bipolar disorder). They reduce symptoms
Chapter 4 Central Nervous System
Chapter 4 page number 1 Chapter 4 Central Nervous System First line drugs Drugs recommended in both primary and secondary care Second line drugs Alternatives (often in specific conditions) in both primary
Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
Formulary and Prescribing Guidelines
Formulary and Prescribing Guidelines SECTION 3: TREATMENT OF BIPOLAR AFFECTIVE DISORDER This section provides information regarding the pharmacological management of Bipolar affective disorder in secondary
Therapeutic Drugs Monitoring TDM 2016 Therapeutic Drugs Monitoring Scheme Application Form
complete all sections below and return to LGC Standards Proficiency Testing by email, fax or post. Returning customer Lab ID: TM Purchase order no.: (compulsory) TDM Distribution Schedule Samples for the
SMOKING AND DRUG INTERACTIONS
Medicines Information Centre Pharmacy Department UK Medicines Information SMOKING AND DRUG INTERACTIONS Introduction Smoking rates are significantly higher among people with mental health problems. It
Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay
Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay (Revised edition November 2015) The Medicine Related Falls Risk Assessment
Medically Accepted Indications for Pediatric Use of Psychotropic Medications by
Key: White Background: Medically Accepted Indication Yellow Backgroun: Medically Accepted Indication Status Not Ascertained Orange Background: Pediatric Indication cited, but not supported Red Background:
Step Therapy Medications
Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,
Manual of Clinical Psychopharmacology
Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School
Study Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
Professor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065
ARABIIC Professor David Castle Ms. Nga Tran St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065 (03) 9288 4147 (03) 9288 4751 Psychiatric Medication Information / Arabic 1 Psychiatric
Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015
Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A 294.3 for use in Northern Ireland) Sep 2015 BNF 1.3.5 Proton pump inhibitors Lansoprazole orodispersible
GUIDELINES FOR THE USE OF PSYCHOACTIVE MEDICATIONS IN INDIVIDUALS WITH CO-OCCURRING SUBSTANCE USE DISORDERS
City and County of San Francisco Mayor Gavin Newsom Department of Public Health Community Behavioral Health Services 1380 Howard Street 5 th Floor San Francisco, CA 94103 GUIDELINES FOR THE USE OF PSYCHOACTIVE
FORMULARY AND PRESCRIBING GUIDELINES FOR CHILDREN AND ADOLESCENTS IN MENTAL HEALTH SERVICES
FORMULARY AND PRESCRIBING GUIDELINES FOR CHILDREN AND ADOLESCENTS IN MENTAL HEALTH SERVICES Version Control Summary Version Date Section(s) Author Comment(s)/Amendments 1 August 2008 All Sections Gbemi
3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: HYDROMORPHONE (DILAUDID, EXALGO), CYCLOBENZAPRINE (FLEXERIL), METHADONE (METHADOSE),
Drugs used for the treatment of depression Selective Serotonin Reuptake Inhibitors Tricyclic and related antidepressants Others antidepressants
Central Nervous System Drugs used for the treatment of depression Anxiolytics and hypnotics Drugs used in psychosis and related disorders Drugs used in substance dependence for patients with established
Kern Pharma Portfolio 2014
Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN
* * * * * INTRODUCTION
Psychiatria Danubina, 2011; Vol. 23, No. 3, pp 320-324 Medicinska naklada - Zagreb, Croatia Conference paper AVAILABILITY OF PSYCHIATRIC MEDICATIONS TO CROATIAN HEALTHCARE USERS AND THE INFLUENCE OF AVAILABILITY
MEDICINES FORMULARY JANUARY This version supersedes all previous versions for Medicines Formulary
EDICIES FORULARY JAUARY 2017 This version supersedes all previous versions for edicines Formulary olicy title edicines Formulary olicy HA05 reference olicy category harmacy Relevant to All staff handling
Medicines used in Mental Health
Publication Report Medicines used in Mental Health Years 24/5 to 214/15 Publication date 13 October 215 A National Statistics Publication for Scotland Contents Introduction... 2 Hypnotics & Anxiolytics...
Retrospective Drug Use Review for the Use of Psychotropic Medications in Children
Retrospective Drug Use Review for the Use of Psychotropic Medications in Children Recommendations Send providers an annual request for additional clinical data for children receiving any of the following
PRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline
Drug name APPENDIX T - Unit costs of anti-epileptic drugs for 2012 guideline Unit costs and weighted average unit costs for drug used in the treatment of focal and generalised epilepsies Prescription Cost
Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials
SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services DRIVING AND MENTAL HEALTH CONDITIONS AND TREATMENTS General information Driving while impaired by a physical
What s New 2003? What new treatments? What have you discontinued? More information please!
What s New 2003? What new treatments? What have you discontinued? More information please! 1 What s New 2003? Submissions = 137 UK = 52 (38%) Doctors = 60% Nurses = 25% Pharmacists = 15% 2 What s New?
Drug Adherence Assessment Report
Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)
Psychotropic Drug Therapy in Adults with Learning Disability. Steve Wilkinson
Psychotropic Drug Therapy in Adults with Learning Disability Steve Wilkinson Outline and Aims of the Session Drug use in learning disability Two distinct areas of drug therapy I. Treatment of common psychiatric
3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.
Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED
Faculty of dentistry Second year CND Course CNS Drugs Dr. Ali Awadallah
Faculty of dentistry Second year CND Course CNS Drugs Dr. Ali Awadallah 0912320825 Drugs that act upon the central nervous system (CNS) influence the lives of everyone, everyday. Drugs that affect the
Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence
Drug Gene(s)/Level of evidence Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Haloperidol CYP2D6 ( SLC6A5 ( 2D6: DPWG guidelines Reduce dose by 50% in PMs Aripiprazole
Medicines used in Mental Health
Publication Report Medicines used in Mental Health Years 26/7 to 216/17 Publication date 1 October 217 A National Statistics Publication for Scotland Contents Introduction... 2 Hypnotics & Anxiolytics...
POSTPARTUM MOOD DISORDERS Identification and Treatment Cheryl Carroll CNM, PMHNP Psych Retreat Greensboro, NC
POSTPARTUM MOOD DISORDERS Identification and Treatment Cheryl Carroll CNM, PMHNP 2017 Psych Retreat Greensboro, NC Postpartum Depression DSM 5 Major Depressive Disorder Diagnostic Criteria specifer: with
2015 Annual Physician Notice
0 Annual Physician Notice The Office of Inspector General (OIG) recommends clinical laboratories send notices to physicians and other providers who use their services, at least once a year, to inform the
NorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
Index. baclofen 73 basal forebrain nuclei 174
Index acetazolamide 33 acetylcholine esterase inhibitor 174 actigraphy 14 activity meter 226 acute insomnia 4 α1 adrenergic activity 88 α 1 containing receptor 211 adenosine 108 advanced sleep phase syndrome
Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI
Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT
PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5
Abiraterone Tablet 250 mg Q4 2015 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Q4 2014 Alendronic Acid Tablet 70 mg Available Amisulpride Tablet 50 ; 100 ; 200 ; 400 mg Available
- how many anti-depressant pills were prescribed to patients in years 2011/12/13
NHS Wet Kent Clinical Commiioning Group Our Ref: FOI.14.WK0196 RE: FREEDOM OF INFORMATION REQUEST Thank you for your requet for information under the Freedom of Information Act 2000 received on 25 February
NSFT Formulary Contents
NSFT Formulary Contents Traffic Light Status... 2 Clinical Commissioning Groups... 2 Antipsychotics... 3 General Prescribing Information... 3 Typical Antipsychotics... 5 Atypical antipsychotics... 10 General
NATIONAL PRESCRIBING INDICATORS DRUG BASKETS
NATIONAL PRESCRIBING INDICATORS 2014 2015 DRUG BASKETS INTRODUCTION The National Prescribing Indicators (NPIs) 2014 2015 were developed by the All Wales Prescribing Advisory Group (AWPAG), and underwent
Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD
Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be
Special Project. National Mental Health Benchmarking Project Forensic Forum. Seclusion Medication Audit
National Mental Health Benchmarking Project Forensic Forum Special Project Seclusion Medication Audit A joint Australian, State and Territory Government Initiative October 2007 National Benchmarking Project
A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
Appendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG
List of changes in Out-Patients Formulary
List of changes in Out-Patients Formulary Change in prescriber criteria Alpha Tocopheryl (Vitamin E) suspension 100mg/mL, tablets 50-150mg, tablets 670mg Atorvastatin tablets Bezafibrate tablets 400mg
3. Atypical antidepressants
3. Atypical antidepressants Bupropion, mirtazapine, nefazodone & trazodone. Mixed group that act at several different sites. Bupropion Acts as a weak dopamine & NE reuptake inhibitor. Has short half-life.
NSFT Formulary Contents Error! Bookmark not defined.
NSFT Formulary Contents Traffic Light Status... 2 Clinical Commissioning Groups... 2 Typical Antipsychotics... 3 General Prescribing Information... 3 Atypical antipsychotics... 7 General Prescribing Information...
SAMPLE REPORT MENTAL HEALTH DNA INSIGHT LABORATORY INFO. Protected Health Information. SSRIs. TCAs. Other Antidepressants
Test Results Reviewed & Approved by: Laboratory Director, Nilesh Dharajiya,.D. ENTAL HEALTH DNA INSIGHT PERSONAL DETAILS DOB Jan 1, 19XX ETHNICITY Caucasian ORDERING HEALTHCARE PROFESSIONAL Glenn Braunstein.D.
TOP APS DRUGS - DIVALPROEX SODIUM BRAND NAME: DEPAKOTE (ER)
divalproex sodium TOP APS DRUGS - DIVALPROEX SODIUM BRAND NAME: DEPAKOTE (ER) Pharmacodynamics study of what a drug does to the body Divalproex sodium is chemically compounded from sodium valproate and
Medicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
A. Incorrect! Seizures are not typically linked to alcohol use. B. Incorrect! Epilepsy is a seizure that is commonly associated with convulsions.
Pharmacology - Problem Drill 17: Central Nervous System Depressants Question No. 1 of 10 Instructions: (1) Read the problem statement and answer choices carefully (2) Work the problems on paper as 1. occur(s)
Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018
MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES Holly Altenberger, PharmD, RPh Director of Pharmacy O Connell Pharmacy holly@oconnellpharmacy.com Objectives At the conclusion of the